Atara Biotherapeutics
ATRA
ATRA
82 hedge funds and large institutions have $57.9M invested in Atara Biotherapeutics in 2024 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 28 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
15% less call options, than puts
Call options by funds: $33K | Put options by funds: $39K
29% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 24
Holders
82
Holding in Top 10
–
Calls
$33K
Puts
$39K
Top Buyers
| 1 | +$4.44M | |
| 2 | +$4.34M | |
| 3 | +$3.4M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$2.88M |
| 5 |
VPC
Vestal Point Capital
New York
|
+$1.94M |
Top Sellers
| 1 | -$2.49M | |
| 2 | -$1.78M | |
| 3 | -$1.55M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.16M |
| 5 |
JPMorgan Chase & Co
New York
|
-$581K |